| Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHD MQ Salas, S Prem, EG Atenafu, A Datt Law, W Lam, Z Al-Shaibani, ... Bone Marrow Transplantation 55 (9), 1773-1783, 2020 | 39 | 2020 |
| Low rates of acute and chronic GVHD with ATG and PTCy in matched and mismatched unrelated donor peripheral blood stem cell transplants S Prem, EG Atenafu, Z Al‐Shaibani, D Loach, A Law, W Lam, FV Michelis, ... European Journal of Haematology 102 (6), 486-493, 2019 | 34 | 2019 |
| Pilot prospective study of frailty and functionality in routine clinical assessment in allogeneic hematopoietic cell transplantation MQ Salas, EG Atenafu, O Bascom, L Wilson, W Lam, AD Law, I Pasic, ... Bone Marrow Transplantation 56 (1), 60-69, 2021 | 27 | 2021 |
| Safety and efficacy of haploidentical peripheral blood stem cell transplantation for myeloid malignancies using post-transplantation cyclophosphamide and anti-thymocyte … MQ Salas, AD Law, W Lam, Z Al-Shaibani, D Loach, DDH Kim, ... Clinical Hematology International 1 (2), 105-113, 2019 | 25 | 2019 |
| Acinetobacter baumannii septicemia in a recipient of an allogeneic hematopoietic stem cell transplantation KA Al-Anazi, B Abdalhamid, Z Alshibani, K Awad, A Alzayed, H Hassan, ... Case reports in transplantation 2012, 2012 | 25 | 2012 |
| Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplant R Alblooshi, S Kanfar, B Lord, EG Atenafu, FV Michelis, I Pasic, A Gerbitz, ... European Journal of Haematology 106 (1), 32-39, 2021 | 24 | 2021 |
| Reduced intensity allogeneic stem cell transplant with anti‐thymocyte globulin and post‐transplant cyclophosphamide in acute myeloid leukemia MQ Salas, S Prem, EG Atenafu, AD Law, W Lam, Z Al‐Shaibani, D Loach, ... European Journal of Haematology 103 (5), 510-518, 2019 | 20 | 2019 |
| Post-transplant cyclophosphamide combined with anti-thymocyte globulin as graft-versus-host disease prophylaxis for allogeneic hematopoietic cell transplantation in high-risk … W Alanazi, S Chen, JH Lipton, DD Kim, A Viswabandya, R Kumar, W Lam, ... Acta Haematologica 144 (1), 66-73, 2021 | 15 | 2021 |
| Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia G Daher-Reyes, TH Kim, I Novitzky-Basso, KH Kim, A Smith, T Stockley, ... Bone Marrow Transplantation 56 (8), 1908-1918, 2021 | 13 | 2021 |
| High incidence but low mortality of EBV-reactivation and PTLD after alloHCT using ATG and PTCy for GVHD prophylaxis MQ Salas, S Prem, M Remberger, W Lam, DDH Kim, FV Michelis, ... Leukemia & Lymphoma 61 (13), 3198-3208, 2020 | 11 | 2020 |
| Impact of CD34+ cell dose on reduced intensity conditioning regimen haploidentical hematopoietic stem cell transplantation MQ Salas, EG Atenafu, MR Bautista, S Prem, W Lam, A Datt Law, ... European Journal of Haematology 104 (1), 36-45, 2020 | 11 | 2020 |
| Reduced‐intensity conditioning allogeneic transplant with dual T‐cell depletion in myelofibrosis MQ Salas, W Lam, AD Law, D Kim, FV Michelis, D Loach, Z Al‐Shaibani, ... European Journal of Haematology 103 (6), 597-606, 2019 | 9 | 2019 |
| Roseomonas bacteremia in a recipient of an allogeneic hematopoietic stem cell transplantation ASA Al-Anazi KA, AlHashmi H, Abdalhamid B, AlSelwi W, AlSayegh M, Alzayed A ... Transplant Infect Dis, 2013 | 9 | 2013 |
| Less is more: superior graft-versus-host disease-free/relapse-free survival with reduced-intensity conditioning and dual T cell depletion in acute myelogenous leukemia MQ Salas, S Chen, W Lam, I Pasic, A Gerbitz, FV Michelis, Z Al-Shaibani, ... Biology of Blood and Marrow Transplantation 26 (8), 1511-1519, 2020 | 8 | 2020 |
| Predictors of outcomes of therapy-related acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation RV Nampoothiri, AD Law, W Lam, C Chen, Z Al-Shaibani, D Loach, ... Hematology/Oncology and Stem Cell Therapy, 2021 | 6 | 2021 |
| Outcomes of therapy‐related acute lymphoblastic leukemia in adults after allogeneic stem cell transplantation R Vasudevan Nampoothiri, AD Law, W Lam, C Chen, Z Al‐Shaibani, ... European Journal of Haematology 105 (1), 24-29, 2020 | 6 | 2020 |
| Progressive multifocal leukoencephalopathy due to John Cunningham (JC) virus following allogeneic haematopoietic cell transplantation W Lam, Z Al-Shaibani, D Kumar, A Viswabandya, S Thyagu, FV Michelis, ... Antiviral Therapy 22 (8), 721-725, 2017 | 5 | 2017 |
| Comparison of the prognostic ability of the HCT-CI, the modified EBMT, and the EBMT-ADT pre-transplant risk scores for acute leukemia E Al-Shaibani, S Cyriac, S Chen, JH Lipton, DD Kim, A Viswabandya, ... Clinical Lymphoma Myeloma and Leukemia 21 (6), e559-e568, 2021 | 4 | 2021 |
| Dual T cell depletion with anti-thymocyte globulin and post-transplant cyclophosphamide results in low rates of cytokine release syndrome in peripheral blood haplo … MQ Salas, W Lam, Z Al-Shaibani, A Viswabandya, AD Law Biology of Blood and Marrow Transplantation 25 (12), e387-e388, 2019 | 4 | 2019 |
| Risk Factors for primary and secondary graft failure in allogenic hematopoietic cell transplantation: A single center study Z Al-Shaibani, ALS Eshrak, M Remberger, W Lam, A Law, FV Michelis, ... Blood 134, 2046, 2019 | 4 | 2019 |
